520 results
Page 3 of 26
8-K
EX-99.1
4ggmr8rv ro7f6x4h
17 Mar 21
CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results
4:08pm
8-K
EX-1.1
wuadxx1a288mbkghvis
15 Jan 21
Entry into a Material Definitive Agreement
5:27pm
424B5
mqj237fgu94e9il
15 Jan 21
Prospectus supplement for primary offering
5:23pm
8-K
EX-99.1
4l3inz
10 Nov 20
CTI BioPharma Reports Third Quarter 2020 Financial Results
4:15pm
8-K
EX-99.1
yykdw1xr32ekb1
29 Sep 20
Other Events
4:49pm
8-K
EX-99.1
9g1o8yl
6 Aug 20
CTI BioPharma Reports Second Quarter 2020 Financial Results
4:13pm
8-K
EX-99.1
1s51zadrzai20gaj7w
7 May 20
CTI BioPharma Reports First Quarter 2020 Financial Results
4:05pm
8-K
ri1stb
22 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
EX-99.1
v8x0f3mgb5
12 Mar 20
CTI BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm
424B5
n261nl v4g7wmqvc249l
14 Feb 20
Prospectus supplement for primary offering
8:14am
8-K
EX-3.1
zmggqvmjnde
14 Feb 20
Material Modifications to Rights of Security Holders
7:17am
8-K
EX-99.8
ff59ddvyug5m2cufsr
14 Feb 20
Material Modifications to Rights of Security Holders
7:17am